Price action
Daily adjusted bars
Snapshot
Key stats
- Market cap
- $77.0M
- P/E ratio
- --
- Forward P/E
- --
- Beta
- -1.10
- 52W range
- $2.16 - $16.00
- Dividend yield
- --
- Volume
- 45.9K
- Sector
- HEALTHCARE
Analyst
Consensus price target
Current
$14.46
Target
$8.00
AlphaYou verdict
Insider Buy
Insider bought $227K of RLYB this 14d.
- Smart money5.1/40
- Fundamentals3.0/35
- Technicals5.0/15
- Macro1.9/10
Receipts
Recent signals for this ticker
- LONGMay 21Insider Buy
Insider bought $227K of RLYB this 14d.
Public Recommendation·Checkpoints pending - ContextMay 16Insider Buy
Insider bought $1.1M of RLYB this 14d.
Watch · Mixed Evidence·Checkpoints pending - LONGMay 14Insider Buy
Insider bought $711K of RLYB this 14d.
Public Recommendation·Checkpoints pending
Smart money
Insider, fund, and political flow
insider buy
10% owner ADAR1 Capital Management, LLC bought $227K
short interest change
short-volume tape softening: latest 33.2% fell 14.0pp vs 20d avg 47.2%
insider buy
10% owner ADAR1 Capital Management, LLC bought $1.1M
insider buy
10% owner ADAR1 Capital Management, LLC bought $711K
short interest change
short-volume tape softening: latest 15.1% fell 32.6pp vs 20d avg 47.7%
Top trader activity
PendingCopy-trading signal layer from real US-equity operators. Wires in once the CopyTrading feed is mapped to US-stock tickers.
BTC Astro risk regime
PendingCross-asset risk timing overlay. Used as context only, never a primary stock source.
Reputation
Sources and actors behind this ticker
Source families
- SEC EDGAR Form 4
Source family
D7
92
+2.22%
66.3% hit
D15
28
+1.41%
60.7% hit
D30
pending
Actors and filers
D7
2
+0.76%
50.0% hit
D15
pending
D30
pending
Checkpoint ledger
Public recommendation outcomes
No public recommendation checkpoints have landed for this ticker yet.
D7 appears first, then D15 and D30 as the call matures.
Each row is a public recommendation. Alpha columns compare the frozen issued price with SPY, QQQ, and sector ETF checkpoints when available.
Raw source coverage
Primary-source receipt chain
Fundamentals
Valuation, quality, growth
Valuation
- P/E--
- Forward P/E--
- P/S89.72
- P/B1.55
Quality
- Profit margin0.0%
- Operating margin-4119.0%
- ROE-15.0%
- ROA-33.8%
Growth
- Revenue YoY--
- Earnings YoY--
- Beta-1.10
- Dividend yield--
Technicals
Trend, momentum, levels
Trailing returns
- 5d-5.98%
- 20d+61.02%
- 60d+37.65%
Trend vs SMAs
- vs SMA50+33.98%
- vs SMA200+111.68%
52w range position
Computed from AV daily adjusted bars. No options-flow, IV, or order-book signals on this page yet.
Macro
Sector + regime context
- +18.1
macro regime shift
VIX 18.1 (mild) as of 2026-05-19
- +0.5
macro regime shift
10y-2y spread 54bps (flattish) as of 2026-05-19
- +102.5
macro regime shift
Industrial Production 102.5 (mild expansion) as of 2026-04-01
- +1.0
macro regime shift
Initial claims 211,000 vs 26w mean (ratio 0.99, neutral)
- +4.0
macro regime shift
CPI YoY 3.95% (hot vs Fed target)
Earnings
EPS beat / miss history
Debate
Key issues
Bullish view
- 10% owner ADAR1 Capital Management, LLC bought $227K
- short-volume tape softening: latest 33.2% fell 14.0pp vs 20d avg 47.2%
- 10% owner ADAR1 Capital Management, LLC bought $1.1M
- 10% owner ADAR1 Capital Management, LLC bought $711K
Bearish view
No receipts on this side yet.
Arguments are pulled from contributing receipts (Form 4 / 13F / fundamentals / macro) for this ticker. Each side carries the count of receipts behind it, not an analyst headline count.
Track record
Recommendation receipts
vs SPY
S&P 500
Median alpha
+0.76%
Mean alpha
+1.59%
Hit rate
50.0%
Mean return
+2.54%
vs QQQ
Nasdaq-100
Median alpha
-0.01%
Mean alpha
+0.79%
Hit rate
50.0%
Mean return
+2.54%
D7 recommendation-counted alpha. Each receipt aggregates same-day same-direction signals into one row to avoid double-counting.